­
­
­
­

Inventi Impact - Urology & Nephrology
(Formerly Inventi Rapid/Impact: Kidney)

  • Journal Image
    Journal Scope:

    Quarterly published in print and online ‘Inventi Rapid/Impact: Urology & Nephrology (Formerly Inventi Rapid/Impact: Kidney)’ publishes high quality unpublished as well as high impact pre-published research and reviews catering to the needs of researchers and professionals. The journal welcomes papers in all the areas of nephrology practices and clinical research. It encourages submissions of latest findings related to pathogenesis and treatment of kidney diseases, hypertension, acid-base and electrolyte disorders, dialysis therapies, and kidney transplantation.

  • STUDY ON ASSESSMENT OF PREVALENCE OF ANAEMIA AND ITS MANAGEMENT IN CHRONIC RENAL FAILURE
    Anju Mathew*, Abubaker Siddiq, Sandeep G N    Download Full Text

    Anaemia is the common comorbidity in patients with chronic kidney disease (CKD). Clinical studies have shown that erythropoietin-stimulating agents decrease the need for transfusions and improve the quality of life. The objective was to assess prevalence of anemia and its management. A prospective, hospital based study was conducted for a period of six months on 100 dialysis patients suffering fro...

    Read More
  • BILATERAL CONGENITAL HYDRONEPHROSIS IN A TIGER CUB
    K Sujatha, Ch Srilatha, N Sailaja    Download Full Text

    Bilateral congenital hydronephosis was described in a tiger cub; clinically the animal was dull since three days prior to death. Grossly enlargement of both kidneys with abnormal retention of urine in renal pelvis was observed. Slight dilation of renal pelvis, calyces, bulging of renal crest was noticed. In medulla cystic spaces communicated with the pelvis were observed. On detailed examinatio...

    Read More
  • MEDICATION REVIEW CLINIC FOR HAEMODIALYSIS PATIENTS
    Banothu Mohan, Languluri Reddenna, Shaik Ayub Basha, Sree Naga Valli, Dinesh R    Download Full Text

    ESRD is rare, its treatment with dialysis or transplantation is very costly. Interventions to lessen morbidity and cost of care after beginning of dialysis are extremely optional. Drug-related problems (DRPs) are a main source of hospital admissions. One study stated 28% of hospital admissions being due to drug-related problems. Insufficient patient history information is the next leading cause...

    Read More
  • BLOOD AND BREATH PROFILES OF VOLATILE ORGANIC COMPOUNDS IN PATIENTS WITH END-STAGE RENAL DISEASE
    Pawel Mochalski, Julian King, Matthias Haas, Karl Unterkofler, Anton Amann, Gert Mayer    Download Full Text

    Background: Monitoring of volatile organic compounds (VOCs) in exhaled breath shows great potential as a non-invasive method for assessing hemodialysis efficiency. In this work we aim at identifying and quantifying of a wide range of VOCs characterizing uremic breath and blood, with a particular focus on species responding to the dialysis treatment. Methods: Gas chromatography with mass spectromet...

    Read More
  • REGRESSION METHODS FOR INVESTIGATING RISK FACTORS OF CHRONIC KIDNEY DISEASE OUTCOMES: THE STATE OF THE ART
    Julie Boucquemont, Georg Heinze, Kitty J Jager, Rainer Oberbauer, Karen Leffondre    Download Full Text

    Background: Chronic kidney disease (CKD) is a progressive and usually irreversible disease. Different types of outcomes are of interest in the course of CKD such as time-to-dialysis, transplantation or decline of the glomerular filtration rate (GFR). Statistical analyses aiming at investigating the association between these outcomes and risk factors raise a number of methodological issues. The obj...

    Read More
  • VITAMIN D RESISTANCE IN CHRONIC KIDNEY DISEASE (CKD)
    Amay Parikh, Herbert S Chase, Linda Vernocchi, Leonard Stern    Download Full Text

    Background: Previous studies have shown that treatment with ergocalciferol in patients with CKD stage 3 + 4 is not effective with less than 33% of patients achieving a 25-OH vitamin D target of >30 ng/ml. The aim of this study was to test the response to cholecalciferol in CKD. We attempted to replete 25-OH vitamin D to a target level of 40–60 ng/ml using the response to treatment and PTH s...

    Read More